Anti-Rheumatics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2023-28

1
Global Anti-Rheumatics Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Anti-Rheumatics Market Research
Report The latest report by IMARC, titled
Anti-Rheumatics Market Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast
2023-2028 " the global anti-rheumatics market
reached a value of US 62.8 Billion in 2022.
Rheumatoid arthritis is a chronic, autoimmune
disease that affects the joints, articular
tissues, and extra-articular organs. It is a
progressive disorder that results in pain,
inflammation, stiffness, and swelling of joints.
Anti-rheumatics refer to drugs used to manage
different symptoms of rheumatoid arthritis and
modify the course of the disease. They can be
administered subcutaneously (SC), orally, or
intravenously (IV) into the body of the patient.
Anti-rheumatics are also used to treat various
types of cancer, and bowel, connective tissue,
and autoimmune conditions, such as psoriatic
arthritis, lupus, Sjogren syndrome (SS), systemic
sclerosis (SSc), and systematic lupus
erythematosus. Medical practitioners usually
prescribe the drug to reduce pain, prevent bone
deformity, reduce joint damage, preserve the
structure and function of the joints, slow the
progression of arthritis, and improve the
persons overall function. Request Free Sample
Report https//www.imarcgroup.com/anti-rheumatics
-market/requestsample
4
Report Description and Highlights
Report Description

Global Anti-Rheumatics Market Trends The rising
incidences of rheumatoid arthritis, especially
among the steadily growing geriatric population,
are creating a positive outlook for the market.
Anti-rheumatic drugs are widely used to treat
rheumatoid arthritis and inflammatory diseases
that cause swelling in joints and damage the
eyes, lungs and skin. In line with this, the
increasing incidences of obesity due to unhealthy
eating habits and changing lifestyles of the
masses are further favoring the market growth.
Apart from this, rapid technological advancements
in the field of biosimilars and novel biologic
therapies that act faster than conventional drugs
and are provided in combination with the
disease-modifying anti-rheumatic drug (DMARD) to
patients are providing an impetus to the market
growth. Moreover, the widespread adoption of
prescription-based medications due to the
increasing number of specialized hospitals
worldwide is augmenting the market growth. Other
factors, including the rising expenditure
capacities of consumers, availability of early
diagnosis and treatment options, and continuous
research and development (RD) activities to
lower the side effects of the drug, are
anticipated to drive the market toward growth. On
account of the aforementioned factors, the market
is anticipated to reach a value of US 73.9
Billion by 2028, growing at a CAGR of 2.7 during
2023-2028. Looking forward, the market value is
projected to reach a strong growth during the
forecast period (2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Type Presc
ription-based Drugs Over-the-Counter Dru
gs Breakup by Drug Class Disease Modif
ying Anti-Rheumatics Drugs (DMARD's)
Nonsteroidal Anti-Inflammatory Drugs
(NSAID's) Corticosteroids Uric
Acid Drugs Others Breakup by Route of
Drug Administration Oral Pare
nteral Others Breakup by Distribution C
hannel

6
Report Description and Highlights
Report Description
Hospital Pharmacies Retail Pha
rmacies E-Commerce Breakup by Region
North America United St
ates Canada Asia-Pacif
ic China Japan
India South
Korea Australia
Indonesia Others Eur
ope Germany Fr
ance United Kingdom

7
Report Description and Highlights
Report Description
Italy Spain
Russia Others
Latin America Brazil
Mexico Others
Middle East and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• AbbVie Inc
• Amgen Inc. AstraZeneca plc Biogen Inc. Bristol-My
  ers Squibb Company Celltrion Inc. Eli Lilly and Co
  mpany F. Hoffmann-La Roche AG Johnson Johnsons P
  fizer Inc. Sanofi SA
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/anti-rheumatics-market
  

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us